Literature DB >> 22525199

Hypertension and aortorenal disease in Alagille syndrome.

Joe-Elie Salem1, Eric Bruguiere, Laurence Iserin, Anne Guiochon-Mantel, Pierre-François Plouin.   

Abstract

Alagille syndrome is a rare congenital multisystem disorder that may involve heart disease and pulmonary or peripheral artery stenosis. We report the clinical and radiological presentation of five adult patients with Alagille syndrome, hypertension and renal artery stenosis. All had systolic hypertension and a narrowing of the abdominal aorta, corresponding to a secondary midaortic syndrome. Renovascular disease progressed during follow-up, with increases in blood pressure, decreases in glomerular filtration rate and/or kidney atrophy. A literature review identified several anecdotal reports of Alagille syndrome associated with hypertension, renal artery stenosis and/or midaortic syndrome. We discuss this condition, focusing on diagnosis, differential diagnosis, associated conditions and management. Cardiologists, nephrologists and radiologists should be aware of this rare cause of renovascular hypertension and of the need for clinical, biological and echographic follow-up.

Entities:  

Mesh:

Year:  2012        PMID: 22525199     DOI: 10.1097/HJH.0b013e3283531e1f

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  10 in total

1.  Clinical Features and Genetic Analysis of Pediatric Patients with Alagille Syndrome Presenting Initially with Liver Function Abnormalities.

Authors:  Yan Liu; Hong Wang; Chen Dong; Jie-Xiong Feng; Zhi-Hua Huang
Journal:  Curr Med Sci       Date:  2018-04-30

2.  Whole Exome Sequencing Reveals a Monogenic Cause of Disease in ≈43% of 35 Families With Midaortic Syndrome.

Authors:  Jillian K Warejko; Markus Schueler; Asaf Vivante; Weizhen Tan; Ankana Daga; Jennifer A Lawson; Daniela A Braun; Shirlee Shril; Kassaundra Amann; Michael J G Somers; Nancy M Rodig; Michelle A Baum; Ghaleb Daouk; Avram Z Traum; Heung Bae Kim; Khashayar Vakili; Diego Porras; James Lock; Michael J Rivkin; Gulraiz Chaudry; Leslie B Smoot; Michael N Singh; Edward R Smith; Shrikant M Mane; Richard P Lifton; Deborah R Stein; Michael A Ferguson; Friedhelm Hildebrandt
Journal:  Hypertension       Date:  2018-02-26       Impact factor: 10.190

Review 3.  Renal involvement and the role of Notch signalling in Alagille syndrome.

Authors:  Binita M Kamath; Nancy B Spinner; Norman D Rosenblum
Journal:  Nat Rev Nephrol       Date:  2013-06-11       Impact factor: 28.314

4.  A boy with Alagille syndrome coexisting with mid-aortic syndrome and renovascular hypertension.

Authors:  Koji Yokoyama; Takaomi Minami; Mitsuru Seki; Yuko Okada; Hideki Kumagai; Takanori Yamagata
Journal:  J Cardiol Cases       Date:  2019-09-27

Review 5.  Renovascular hypertension in pediatric patients: update on diagnosis and management.

Authors:  Juliana Lacerda de Oliveira Campos; Letícia Bitencourt; Ana Luisa Pedrosa; Diego Ferreira Silva; Filipe Ji Jen Lin; Lucas Teixeira de Oliveira Dias; Ana Cristina Simões E Silva
Journal:  Pediatr Nephrol       Date:  2021-04-13       Impact factor: 3.714

Review 6.  Alagille syndrome: clinical perspectives.

Authors:  Maha Saleh; Binita M Kamath; David Chitayat
Journal:  Appl Clin Genet       Date:  2016-06-30

Review 7.  Multidisciplinary Management of Alagille Syndrome.

Authors:  Jagadeesh Menon; Naresh Shanmugam; Mukul Vij; Ashwin Rammohan; Mohamed Rela
Journal:  J Multidiscip Healthc       Date:  2022-02-23

Review 8.  Pulmonary artery pathologies in Alagille syndrome: a meta-analysis.

Authors:  Shi-Min Yuan
Journal:  Postepy Kardiol Interwencyjnej       Date:  2022-08-19       Impact factor: 1.065

9.  Hypertension and Biliary Ductopenia in a Patient with Duplication of Exon 6 of the JAG1 Gene.

Authors:  J Uberos; L Moreno; A Muñoz-Hoyos
Journal:  Clin Med Insights Pediatr       Date:  2012-07-26

Review 10.  Diagnosis and Management of Genetic Causes of Middle Aortic Syndrome in Children: A Comprehensive Literature Review.

Authors:  Cecilia Lazea; Camelia Al-Khzouz; Crina Sufana; Diana Miclea; Carmen Asavoaie; Ioana Filimon; Otilia Fufezan
Journal:  Ther Clin Risk Manag       Date:  2022-03-16       Impact factor: 2.423

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.